Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: 17 December 2025
Selective internal radiation therapy for unresectable colorectal metastases in the liverStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Percutaneous cryotherapy (PCT) for the therapy of primary lung cancer or metastatic lung cancerStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
High intensity focused ultrasound ablation for pain caused by bone metastasesStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812Status:Topic prioritisationProgramme:Health technology evaluationExpected publication date: TBC
Subcutaneous pembrolizumab with platinum-based chemotherapy for untreated metastatic non-small-cell lung cancer [TSID12213]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: TBC